Skip to content
Calculadora Capital
MRKStocksNYSEUSD

Merck (MRK): return calculator

Merck & Co. (MRK) shares, one of the world's largest pharmaceutical companies, listed in New York.

US$119.60Latest price · 23 Jun 2026 close

Updated

Type
Stocks
Market
NYSE
Currency
USD
Sector
Healthcare
Data range
2016-07 – 2026-06 · 10 years
Source
Yahoo Finance

US$1,000 invested 9 years ago would be worth today

US$2,600

+160% total return

Try your own values in the calculators below.

Return calculator

Pick an amount and a period to see what an investment in Merck (MRK) would be worth today. By default we include reinvested dividends (total return).

Lump sum

What a one-off investment would be worth today.

Value today
US$1,813
Total return
+81.3%
Annualised return
+12.6%

Monthly investing (DCA)

What investing the same amount every month would be worth.

Value today
US$8,170
Profit
US$2,070
Total invested
US$6,100

Estimate before taxes, fees and currency-conversion costs. Past performance does not guarantee future returns.

Investment growth

US$1,000US$2,904
Growth of US$1,000 invested — 2016-07 to 2026-06.

Performance

Annualised return
+11.35%
Best year (2022)
+50%
Worst year (2020)
-7%
Largest drop
-39.7%

Data for the last 10 years · 2016-072026-06

Comparison with the market

US$1,000 invested vs S&P 500 ETF (SPY):

Merck (MRK)
US$2,904
S&P 500 ETF (SPY)
US$3,849

Merck (MRK) trailed S&P 500 ETF (SPY) over this period.

Risk & drawdowns

The largest peak-to-trough drop in the window was -39.7%. An investor who bought near the prior peak would have seen the investment fall significantly before recovering.

Scenarios

Illustrative results based on the available data.

  • US$1,000 5 years ago

    US$1,813

    lump sum, +81.29129334724495% return

  • US$100/mo for 5 years

    US$8,170

    invested US$6,100

  • If it repeats +11.35%/yr for 10 years

    US$2,930

    projection from US$1,000 (hypothetical)

About Merck (MRK)

Merck & Co. is one of the largest pharmaceutical companies in the world. Its most important medicine is Keytruda, a cancer immunotherapy that is now one of the best-selling drugs on the planet and accounts for a huge share of revenue. It also has a strong vaccines business (such as Gardasil) and an animal-health division.

It trades on the New York Stock Exchange (NYSE) under the ticker MRK and is part of the S&P 500 and Dow Jones indices. It is a defensive, dividend-paying stock. An important distinction: in the United States and Canada it is called Merck & Co., but in the rest of the world it operates as MSD, because there the "Merck" name belongs to the German pharmaceutical company Merck KGaA, a different business.

Related calculators

Other assets

Frequently asked questions

How much did Merck (MRK) return over the last 10 years?
+190.4% in total, or about +11.35% per year, on a total-return basis (dividends reinvested), between 2016-07 and 2026-06.
Do these calculations include dividends?
By default yes (total return). Turn off "include dividends" to see price-only appreciation.
Do they include taxes or fees?
No. These are estimates before taxes, broker fees and currency-conversion costs.
What currency are the values in?
USD. A euro-based investor also carries EUR/USD currency risk, not reflected here.
Does past performance predict the future?
No. Past performance does not guarantee future returns; this is educational information, not advice.

Sources & methodology

Prices: Yahoo Finance. Monthly series, total return (dividends reinvested). Data through 2026-06-23.

Total return assumes dividends are reinvested; you can turn that off to see price-only appreciation. Values are estimates before taxes, fees and currency-conversion costs.

Page generated and reviewed by the Calculadora Capital editorial team. Last updated 2026-06-23.